...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the leiden out-of-hospital cardiac arrest study.
【24h】

Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the leiden out-of-hospital cardiac arrest study.

机译:连续300例缺血性心脏病患者中死于猝死的复发性室性心律失常或死亡的决定因素:来自Leiden院外心脏骤停研究的数据。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Evaluation of the relation between clinical characteristics and incidence of recurrent ventricular arrhythmias (VAs) or death during long-term follow-up in a cohort of 300 consecutive ischemic heart disease (IHD) patients who had survived an episode of sudden cardiac arrest (SCA). Background: Survivors of life-threatening VA are at high risk for recurrent events. METHODS: A total of 300 consecutive survivors of SCA with IHD were included in a standardized screening and evaluation protocol. Multivariable Cox regression analysis was performed to determine the relation between clinical variables at baseline and the incidence of recurrent VA, all-cause mortality and the composite of both (composite endpoint). RESULTS: The presenting arrhythmia was VT in 156 (52%) patients and VF in 144 (48%) patients. Revascularization was performed in 78 (26%) patients and an ICD was implanted in 216 (72%) patients. During follow-up (mean 30 +/- 21 months) 37 (12%) patients died and 88 (29%) patients experienced a recurrence. Advanced age (adjusted hazard ratio (HR) 2.0; 1.2-3.3), history of heart failure (HR 1.8; 1.2-2.6), and amiodarone use (HR 3.1; 2.1-4.6) were independent predictors for the composite endpoint. VT as presenting arrhythmia was an independent predictor for all-cause mortality only (HR 2.4; 1.2-4.8). A decreased risk of recurrences was determined by beta-blocker use (HR 0.5; 0.4-0.8) and coronary revascularization (HR 0.3; 0.2-0.6). CONCLUSION: In a cohort of 300 consecutive survivors of SCA the incidence of recurrent VA and death is dependant on patient age, history of heart failure, and use of amiodarone. In contrast, use of beta-blockers and aggressive coronary revascularization improve the outcome.
机译:目的:评估300例连续性心脏骤停发作幸存下来的连续性缺血性心脏病(IHD)患者的临床特征与长期随访中室性心律失常(VAs)的发生率或死亡之间的关系。 SCA)。背景:危及生命的VA的幸存者极易发生复发事件。方法:标准化筛查和评估方案中共纳入了300名患有IHD的SCA连续幸存者。进行了多变量Cox回归分析,以确定基线时的临床变量与复发性VA的发生率,全因死亡率以及两者的综合(复合终点)之间的关系。结果:出现心律不齐的是156例(52%)患者的VT和144例(48%)的患者的VF。 78例(26%)患者进行了血运重建,216例(72%)患者植入了ICD。在随访期间(平均30 +/- 21个月),有37例(12%)患者死亡,88例(29%)患者复发。高龄(调整后的危险比(HR)2.0; 1.2-3.3),心衰史(HR 1.8; 1.2-2.6)和胺碘酮使用(HR 3.1; 2.1-4.6)是复合终点的独立预测因子。表现为心律不齐的室速仅是全因死亡率的独立预测因子(HR 2.4; 1.2-4.8)。通过使用β受体阻滞剂(HR 0.5; 0.4-0.8)和冠状动脉血运重建术(HR 0.3; 0.2-0.6)可以确定复发的风险降低。结论:在连续300名SCA幸存者中,复发性VA和死亡的发生率取决于患者的年龄,心力衰竭的病史和胺碘酮的使用。相反,使用β受体阻滞剂和积极的冠状动脉血运重建可改善结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号